These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17414885

  • 1. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
    Win Z, Al-Nahhas A, Towey D, Todd JF, Rubello D, Lewington V, Gishen P.
    Nucl Med Commun; 2007 May; 28(5):359-63. PubMed ID: 17414885
    [Abstract] [Full Text] [Related]

  • 2. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS.
    Cancer Imaging; 2016 Aug 17; 16(1):22. PubMed ID: 27535829
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
    Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, Dhillo W, Meeran K, Goldstone AP, Martin NM, Todd JF, Palazzo F, Tan T.
    Eur J Nucl Med Mol Imaging; 2012 Aug 17; 39(8):1266-70. PubMed ID: 22526961
    [Abstract] [Full Text] [Related]

  • 5. Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
    Tan TH, Wong TH, Hassan SZ, Lee BN.
    Clin Nucl Med; 2015 Nov 17; 40(11):867-8. PubMed ID: 26252329
    [Abstract] [Full Text] [Related]

  • 6. 68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
    Gains JE, Aldridge MD, Mattoli MV, Bomanji JB, Biassoni L, Shankar A, Gaze MN.
    Nucl Med Commun; 2020 Nov 17; 41(11):1169-1177. PubMed ID: 32796449
    [Abstract] [Full Text] [Related]

  • 7. 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.
    Naji M, Zhao C, Welsh SJ, Meades R, Win Z, Ferrarese A, Tan T, Rubello D, Al-Nahhas A.
    Mol Imaging Biol; 2011 Aug 17; 13(4):769-75. PubMed ID: 20700766
    [Abstract] [Full Text] [Related]

  • 8. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
    Taïeb D, Sebag F, Hubbard JG, Mundler O, Henry JF, Conte-Devolx B.
    Clin Endocrinol (Oxf); 2004 Jul 17; 61(1):102-8. PubMed ID: 15212651
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.
    J Clin Endocrinol Metab; 2009 Oct 17; 94(10):3922-30. PubMed ID: 19622618
    [Abstract] [Full Text] [Related]

  • 11. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
    Grassi I, Nanni C, Vicennati V, Castellucci P, Allegri V, Montini GC, Pagotto U, di Dalmazi G, Pasquali R, Fanti S.
    Clin Nucl Med; 2011 Feb 17; 36(2):124-6. PubMed ID: 21220975
    [Abstract] [Full Text] [Related]

  • 12. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
    Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, Schober O.
    J Nucl Med; 2006 Oct 17; 47(10):1635-42. PubMed ID: 17015899
    [Abstract] [Full Text] [Related]

  • 13. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.
    J Clin Endocrinol Metab; 2010 Jun 17; 95(6):2800-10. PubMed ID: 20371665
    [Abstract] [Full Text] [Related]

  • 14. 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review.
    AlSadi R, Maaz AUR, Bouhali O, Djekidel M.
    J Nucl Med Technol; 2023 Jun 17; 51(2):140-146. PubMed ID: 37192823
    [Abstract] [Full Text] [Related]

  • 15. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K.
    J Clin Oncol; 2007 Jun 01; 25(16):2262-9. PubMed ID: 17538171
    [Abstract] [Full Text] [Related]

  • 16. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.
    Derlin T, Busch JD, Wisotzki C, Schoennagel BP, Bannas P, Papp L, Klutmann S, Habermann CR.
    Clin Nucl Med; 2013 Jan 01; 38(1):e1-6. PubMed ID: 22996238
    [Abstract] [Full Text] [Related]

  • 17. The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
    Mackenzie IS, Gurnell M, Balan KK, Simpson H, Chatterjee K, Brown MJ.
    Eur J Endocrinol; 2007 Oct 01; 157(4):533-7. PubMed ID: 17893270
    [Abstract] [Full Text] [Related]

  • 18. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
    Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA.
    Ann Surg Oncol; 2006 Feb 01; 13(2):187-97. PubMed ID: 16418883
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul 01; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 20. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
    De Graaf JS, Dullaart RP, Kok T, Piers DA, Zwierstra RP.
    Eur J Surg; 2000 Apr 01; 166(4):289-92. PubMed ID: 10817323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.